SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 70.68 |
| Enterprise Value ($M) | 64.41 |
| Book Value ($M) | 136.81 |
| Book Value / Share | 2.59 |
| Price / Book | 0.52 |
| NCAV ($M) | 106.99 |
| NCAV / Share | 2.03 |
| Price / NCAV | 0.66 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.98 |
| Return on Assets (ROA) | -0.69 |
| Return on Equity (ROE) | -0.90 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.82 |
| Current Ratio | 4.82 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 155.90 |
| Assets | 185.72 |
| Liabilities | 48.91 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G/A | Vivo Capital Fund IX, L.P. | 3.40 | ||
| 13G/A | Fmr Llc | 11.13 | -21.51 | |
| 13G/A | Millennium Management Llc | 3.80 | -32.39 | |
| 13G | Tang Capital Partners Lp | 7.70 | ||
| 13G/A | Orbimed Advisors Llc | 4.50 | -0.49 | |
| 13D/A | LSV Associates, LLC | 5.90 | -29.92 | |
| 13G/A | Redmile Group, LLC | 9.60 | -1.65 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 188,930 | 825,479 | 22.89 | |
| 158,741 | 873,891 | 18.16 | |
| 186,177 | 880,205 | 21.15 | |
| 103,088 | 697,986 | 14.77 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALLK – Allakos Inc. | ALLO – Allogene Therapeutics, Inc. |
| ALNY – Alnylam Pharmaceuticals, Inc. | AMGN – Amgen Inc. |
| AMLX – Amylyx Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io